By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


Company News
CytRx Corporation (CYTR) Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results In Glioblastoma Multiforme (Brain Cancer) 5/21/2015 8:35:36 AM
CytRx Corporation (CYTR) Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage And Improved Quality Of Life In Chemotherapy Resistant Cancers 5/4/2015 7:45:08 AM
CytRx Corporation (CYTR) Reports First Quarter 2015 Financial Results 5/1/2015 8:38:38 AM
CytRx Corporation (CYTR) Announces Publication Of Glioblastoma Clinical Case Study In Journal Of Nuclear Medicine & Radiation Therapy 4/29/2015 7:33:59 AM
Dr. Anita J. Chawla Joins CytRx Corporation (CYTR) Board Of Directors To Add Additional Drug Commercialization Expertise In Oncology 3/11/2015 7:39:09 AM
CytRx Corporation (CYTR) Reports 2014 Financial Results 3/10/2015 10:19:01 AM
CytRx Corporation (CYTR) To Present At The Cowen and Company 35th Annual Health Care Conference 2/25/2015 10:22:48 AM
CytRx Corporation (CYTR) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 9, 2015 In New York City 2/2/2015 11:51:32 AM
CytRx Corporation (CYTR) Announces Overall Survival Results From Its Global Phase 2b Clinical Trial Of Aldoxorubicin In Soft Tissue Sarcoma 1/22/2015 8:12:56 AM
FDA Removes Partial Clinical Hold on CytRx Corporation (CYTR)'s Brain Cancer Trials 1/20/2015 6:41:01 AM